---
title: "Comparing the New Gide MAE with the Gide Version on ORCESTRA and Their QCs"
author:
- name: "Nasim Bondar Sahebi"
  affiliation:
  - UofT, Princess Margaret Cancer Center,University Health Network, Toronto, Ontario, Canada
date: "2024 23 09"
output:
  html_document: default
---


```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE, warning = FALSE, message = FALSE)

```

## load libraries

```{r libraries cars}
library(MultiAssayExperiment) 
library(kableExtra)
library(jpeg)
library(png)
library(grid)
library(gridExtra)
library(ggplot2)
library(dplyr)
library(tidyr)
library(knitr)
library(DESeq2)
library(pheatmap)
library(edgeR)
library(readxl)
library(fgsea)
library(stringr)
```

## Data Loading and Preparation

- **Study Reference**: [PubMed ID 30753825](https://pubmed.ncbi.nlm.nih.gov/30753825/).

### Overview

The goal is to compare the **new Gide MAE** data with the **[Gide version available on ORCESTRA](https://orcestra.ca/clinical_icb)** and assess their quality control (QC) results to ensure consistency in clinical and expression data across both datasets.

### Data Overview

**New MAE Data:**
- **Total Patient Count**: 91 (41 after subsetting to common patients with Orcestra)
- **Expression Data Dimensions**: 61,544 genes across 41 patients (after subsetting)
- **Expression Data Range**: Minimum: -9.965784, Maximum: 16.25238

**Orcestra MAE Data:**
- **Patient Count**: 41 (same as the final subset of the new MAE)
- **Expression Data Dimensions**: 61,544 genes across 41 patients
- **Expression Data Range**: Minimum: -9.965784, Maximum: 16.25415

### Expression Data Comparison Summary
The expression data between the new MAE and Orcestra MAE datasets is **identical** in terms of dimensions and range, ensuring consistency:

Load multiassay .rds file, extract clinical, expression and annotations data; prepare gene expression data for analysis.

```{r multiassay extraction}

# Load MultiAssayExperiment objects
mae <- readRDS("~/BHK lab/ICB/ICB_Gide/output/ICB_Gide.rds")
mae_orcestra <- readRDS("~/BHK lab/ICB/ICB_Gide/output/ICB_GideOrcestra.rds")

# Extract clinical data
clin <- data.frame(colData(mae))         # 91 x 51
clin_orc <- data.frame(colData(mae_orcestra))  # 41 x 38

# Identify patients with "PRE" visit and check if they exist in clin_orcestra
pre_patients <- clin$patient[clin$treatment_timepoint == "PRE"]
missing_patients <- setdiff(pre_patients, clin_orc$patientid)

cat("Number of patients with 'PRE' visit not in clin_orcestra:\n", length(missing_patients), "\n")
cat("Missing patient IDs:\n", missing_patients, "\n")

# NOTE: The "$treatment_timepoint" column comes from the data shared with the author.
# From this, we conclude that the Gide MultiAssayExperiment from Orcestra is missing 32 "PRE" samples.
# The next step is to subset the new MAE to include only samples present in clin_orcestra for further comparisons.

# Subset to common patients between clin and clin_orcestra
patients <- clin_orc$patientid
columns <- colnames(clin_orc)
clin_subset <- clin[patients, columns]  # Subset to common patients (41 x 38)

# Print assay names for both mae objects
cat("Assay names in mae:\n", names(mae), "\nAssay names in mae_orcestra:\n", names(mae_orcestra), "\n")

# Extract expression data for comparison
expr <- assays(mae)[["expr_gene_tpm"]] 
expr <- expr[, clin_subset$patientid]  # Subset expression data to common patients (61544 x 41)

expr_orc <- assays(mae_orcestra)[["expr_gene_tpm"]]  

# Create a table comparing dimensions and ranges of the two expression datasets
comparison_table <- data.frame(
  Dataset = c("expr", "expr_orc"),
  Dimensions = c(paste(dim(expr), collapse = " x "), paste(dim(expr_orc), collapse = " x ")),
  Range_Min = c(min(range(expr)), min(range(expr_orc))),
  Range_Max = c(max(range(expr)), max(range(expr_orc)))
)

kable(comparison_table, caption = "Expression comparison between expr and expr_orc")


# an optional chceking Rnaseq column shared woth both clinical data
# Check the RNA sequencing info consistency between clin_orc and clin_subset
rna_seq_comparison <- data.frame(
  Dataset = c("clin_orc", "clin_subset"),
  PRE = c(table(clin_orc$RNA.Sequencing)["PRE"], table(clin_subset$RNA.Sequencing)["PRE"]),
  `PRE and EDT` = c(table(clin_orc$RNA.Sequencing)["PRE and EDT"], table(clin_subset$RNA.Sequencing)["PRE and EDT"])
)

# Optionally, format the table using kable for a nicer output
kable(rna_seq_comparison, caption = "Comparison of RNA.Sequencing Column between clin_orc and clin_subset") 

```

## Comparison of Column Summaries between `clin_subset` and `clin_orc`

- Both datasets (`clin_subset` and `clin_orc`) are **identical** in structure and content for most columns.
- **Numerical and categorical data** (e.g., `age`, `sex`, `treatmentid`) show no differences in values or types.
- Columns like `histo`, `stage`, and `TMB_raw` contain **only NA values** in both datasets.
- The **only inconsistency** is in `Days.to.EDT.Biopsy` (numeric in `clin_subset`, character in `clin_orc`).

```{r clinical Comparison }


# Add "orcestra_" prefix to the clin_orc columns for clarity
colnames(clin_orc) <- paste0("orcestra_", colnames(clin_orc))

# Merge the clin and clin_orc datasets for comparison
merged_clinical <- merge(clin_subset, clin_orc, by.x = "patientid", by.y = "orcestra_patientid", all = TRUE)

# Display the head of merged_clinical with a customized caption
kable(head(merged_clinical), caption = "Head of Merged Clinical Data (Note: Columns starting with 'orcestra_' (e.g., orcestra_sex) are from the Orcestra dataset, while other columns (e.g., sex) come from the newly curated MultiAssay dataset)") %>%
  kable_styling(bootstrap_options = c("striped", "hover", "condensed"), full_width = F)


# Next step is to compare each columns together  

# Initialize an empty df to store result 
comparison_results <- data.frame(Column = character(), Clin_Subset_Summary = character(), Clin_Orc_Summary = character(), stringsAsFactors = FALSE)

# Loop through columns in clin_subset and clin_orc and compare them directly
for (col in colnames(clin_subset)) {
  orcestra_col <- paste0("orcestra_", col)
  
  if (orcestra_col %in% colnames(clin_orc)) {
    # Capture summary of clin_subset
    clin_subset_summary <- capture.output(summary(clin_subset[[col]]))
    clin_orc_summary <- capture.output(summary(clin_orc[[orcestra_col]]))
    
    # Combine summaries into one data frame
    comparison_results <- rbind(comparison_results, 
                                data.frame(Column = col, 
                                           Clin_Subset_Summary = paste(clin_subset_summary, collapse = " "), 
                                           Clin_Orc_Summary = paste(clin_orc_summary, collapse = " "),
                                           stringsAsFactors = FALSE))
  }
}

# Display the comparison table using kable
kable(comparison_results, caption = "Comparison of Column Summaries between clin_subset and clin_orc") %>%
  kable_styling(bootstrap_options = c("striped", "hover", "condensed"), full_width = F) %>%
  scroll_box(width = "100%", height = "500px")

```

## Quality Control Comparison Between Two Curated Datasets

### Aim:
To generate Table 1 and Figure 2 (A and B) from the paper [PubMed ID 30753825](https://pubmed.ncbi.nlm.nih.gov/30753825/).

### Objective:
Compare our new clinical data (91 patients) and `clin_orc` data (41 patients) to the published study (120 patients) for key characteristics and outcomes in Anti-PD-1 Monotherapy and Combined Anti-PD-1 with Anti-CTLA-4 Immunotherapy cohorts.

- **Published Study**: 63 monotherapy, 57 combination therapy patients.
- **New 'clin' Data**: 50 monotherapy, 41 combination therapy patients.
- **clin_orc Data**: 41 monotherapy patients, with about 22 missing; however, the newer curated data shows fewer differences (13).

### Summary of Findings:

- **Age (years), median**:
  - **Published Study**: Monotherapy Non-responders: 64, Responders: 69; Combo Non-responders: 55, Responders: 57.
  - **New 'clin' Data**: Monotherapy Non-responders: 67, Responders: 62; Combo Non-responders: 51, Responders: 65.
  - **clin_orc**: Monotherapy Non-responders: 66, Responders: 66.
  - **Insight**: Age trends are similar across datasets, with minor differences.

- **Gender Breakdown (Male %)**:
  - **Published Study**: Monotherapy Non-responders: 67%; Responders: 55%; Combo Non-responders: 62%, Responders: 66%.
  - **New 'clin' Data**: Non-responders: 73.9%; Responders: 59.3%; Combo: 63.6%, 66.7%.
  - **clin_orc**: Non-responders: 73.7%; Responders: 54.5%.
  - **Insight**: Gender distribution is consistent across datasets.

- **Treatment Response (CR/PR)**:
  - **Published Study**: Monotherapy CR/PR: 45%; Combo: 53%.
  - **New 'clin' Data**: Monotherapy CR/PR: 46%; Combo: 53%.
  - **clin_orc**: Monotherapy CR: 0, PR: 19.
  - **Insight**: Responses align well, but `clin_orc` shows no CR in monotherapy.

- **Progression-Free Survival (PFS, months)**:
  - **Published Study**: Monotherapy: 2.6; Combo: 2.7.
  - **New 'clin' Data**: Monotherapy: 2.6 for non-responders, 29 for responders; Combo: 2.7 for non-responders, 20.1 for responders.
  - **clin_orc**: Monotherapy: 2.6 for non-responders, 17.7 for responders.
  - **Insight**: Close alignment, with slight variations in responder data.

- **Overall Survival (OS, months)**:
  - **Published Study**: Monotherapy 12-month OS: 89% responders; Combo: 67.7% for non-responders.
  - **New 'clin' Data**: Monotherapy 12-month OS: 96.3% responders, 21.7% non-responders; Combo: 86.7% responders, 54.5% non-responders.
  - **clin_orc**: Monotherapy 12-month OS: 21.1% for non-responders.
  - **Insight**: Higher OS rates in our data, especially among responders, likely due to smaller sample size.

### Result:
Our dataset aligns closely with the published study regarding clinical characteristics and outcomes, with minor differences expected due to cohort sizes. The newer dataset is likely more accurate than the `clin_orc` data.


```{r Table1}

# Revert back the "orcestra_" prefix from column names
colnames(clin_orc) <- gsub("^orcestra_", "", colnames(clin_orc))

# Function to process clinical data and generate a summary table with dynamic n values
generate_clinical_summary <- function(clin_data) {
  
  # Define responder and non-responder groups based on the criteria
  clin_data$response_paper <- ifelse(
    (clin_data$recist %in% c("CR", "PR") | (clin_data$recist == "SD" & clin_data$survival_time_pfs > 6)), 
    "Responder", 
    ifelse(clin_data$recist == "PD" | (clin_data$recist == "SD" & clin_data$survival_time_pfs <= 6), 
           "Non-responder", 
           NA)
  )
  
  # Subset data to mono and combo
  monotherapy <- clin_data %>% filter(treatment == "PD-1/PD-L1")
  combo_therapy <- clin_data %>% filter(treatment == "IO+combo")
  
  # Count the number of responders and non-responders for dynamic n values
  monotherapy_n <- monotherapy %>% group_by(response_paper) %>% summarize(n = n())
  combo_therapy_n <- combo_therapy %>% group_by(response_paper) %>% summarize(n = n())

  # Generate detailed summary statistics
  generate_detailed_summary <- function(data) {
    data %>%
      group_by(response_paper) %>%
      summarize(
        `Age (years), median` = as.character(round(median(age, na.rm = TRUE), 1)),
        Male = paste0(sum(sex == "M", na.rm = TRUE), " (", round(sum(sex == "M", na.rm = TRUE) / n() * 100, 1), "%)"),
        Female = paste0(sum(sex == "F", na.rm = TRUE), " (", round(sum(sex == "F", na.rm = TRUE) / n() * 100, 1), "%)"),
        `Nivolumab n (%)` = paste0(sum(treatmentid == "Nivolumab", na.rm = TRUE), " (", round(sum(treatmentid == "Nivolumab", na.rm = TRUE) / n() * 100, 1), "%)"),
        `Pembrolizumab n (%)` = paste0(sum(treatmentid == "Pembrolizumab", na.rm = TRUE), " (", round(sum(treatmentid == "Pembrolizumab", na.rm = TRUE) / n() * 100, 1), "%)"),
        CR = as.character(sum(recist == "CR", na.rm = TRUE)),
        PR = as.character(sum(recist == "PR", na.rm = TRUE)),
        SD = as.character(sum(recist == "SD", na.rm = TRUE)),
        PD = as.character(sum(recist == "PD", na.rm = TRUE)),
        `Median PFS (months)` = as.character(round(median(survival_time_pfs, na.rm = TRUE), 1)),
        `12-month PFS (%)` = as.character(round(mean(survival_time_pfs >= 12, na.rm = TRUE) * 100, 1)),
        `Median OS (months)` = as.character(round(median(survival_time_os, na.rm = TRUE), 1)),
        `12-month OS (%)` = as.character(round(mean(survival_time_os >= 12, na.rm = TRUE) * 100, 1))
      )
  }
  
  # Generate summaries
  monotherapy_summary <- generate_detailed_summary(monotherapy) %>% mutate(Therapy = "Monotherapy")
  combo_therapy_summary <- generate_detailed_summary(combo_therapy) %>% mutate(Therapy = "Combination Therapy")
  
  # Combine and reshape the summary
  combined_summary <- bind_rows(monotherapy_summary, combo_therapy_summary) %>%
    pivot_longer(cols = -c(Therapy, response_paper), names_to = "Characteristic", values_to = "Value") %>%
    pivot_wider(names_from = c(Therapy, response_paper), values_from = Value)
  
  # Get the dynamic n values for monotherapy and combo therapy
  monotherapy_non_responder_n <- monotherapy_n %>% filter(response_paper == "Non-responder") %>% pull(n)
  monotherapy_responder_n <- monotherapy_n %>% filter(response_paper == "Responder") %>% pull(n)
  combo_non_responder_n <- combo_therapy_n %>% filter(response_paper == "Non-responder") %>% pull(n)
  combo_responder_n <- combo_therapy_n %>% filter(response_paper == "Responder") %>% pull(n)
  
  # Add number of patients (n) dynamically to column headers
  colnames(combined_summary) <- c("Characteristic",
                                  paste0("Monotherapy Non-responder (n=", monotherapy_non_responder_n, ")"),
                                  paste0("Monotherapy Responder (n=", monotherapy_responder_n, ")"),
                                  paste0("Combination Therapy Non-responder (n=", combo_non_responder_n, ")"),
                                  paste0("Combination Therapy Responder (n=", combo_responder_n, ")"))
  
  # Define row names
  rownames_final <- c("Age (years), median", "Male", "Female", 
                      "Nivolumab n (%)", "Pembrolizumab n (%)", "CR", "PR", 
                      "SD", "PD", "Median PFS (months)", "12-month PFS (%)", 
                      "Median OS (months)", "12-month OS (%)")
  
  rownames(combined_summary) <- rownames_final
  
  return(combined_summary)
}

# Usage example for clin and clin_orc
summary_clin <- generate_clinical_summary(clin)
summary_clin_orcestra <- generate_clinical_summary(clin_orc)

# Display New Gide MAE summary
kable(summary_clin, caption = "New Gide MAE: Clinicopathologic Characteristics", align = "l") %>%
  kable_styling(bootstrap_options = c("striped", "hover", "condensed"), full_width = F)

# Display ORCESTRA Version summary
kable(summary_clin_orcestra, caption = "ORCESTRA Version: Clinicopathologic Characteristics", align = "l") %>%
  kable_styling(bootstrap_options = c("striped", "hover", "condensed"), full_width = F)

```

```{r Table11, fig.width= 20 ,fig.height= 10}
# Read the PNG image
img <- png::readPNG("~/BHK lab/ICB/ICB_Gide/files/paper_table1.png")

# Convert the image to a grob
img_grob <- rasterGrob(img, interpolate = TRUE)

# Convert the summary table to a grob
summary_clin_grob <- tableGrob(summary_clin, theme = ttheme_default(
  core = list(fg_params = list(cex = 0.8)),
  colhead = list(fg_params = list(cex = 0.8)),
  rowhead = list(fg_params = list(cex = 0.8))
))

# Arrange the summary table and the image side by side
grid.arrange(summary_clin_grob, img_grob, ncol = 2, widths = c(0.6, 0.4))

```


## Immunotranscriptomic Gene Signatures in Responders and Non-responders to Anti-PD-1 Monotherapy and Combined Anti-PD-1

This study delves into the immunotranscriptomic changes experienced by patients undergoing Anti-PD-1 monotherapy and combination therapy. We aim to delineate the gene expression profiles that distinguish responders from non-responders.

### Dataset Overview
The original paper evaluated 47 PRE samples (35 responders, 12 non-responders) and 15 EDT samples (11 responders, 4 non-responders). Comparatively, our dataset contains 41 PRE and 9 POST samples.

### Analytical Workflow
1. **Differential Gene Expression Analysis**:
   - **Paper's Approach**: Used HTSeq version 0.6.1 and Employed DESeq2 for normalization and differential expression        analysis, aligning closely with the paper's methodology.

2. **Normalization and Read Counts**:
   - Both studies applied the `DESeq()` function for consistent read count normalization.

3. **Visualization of Normalized Expression**:
   - **Paper's Method**: Used counts per million (CPM) for visualization. Similarly we use the `cpm()` function to        ensure comparable visualization of expression data.

4. **Identification of Significant DEGs**:
   - Both analyses adhered to the Benjamini-Hochberg correction for multiple testing, selecting DEGs with an adjusted p-value < 0.05. We identified 320 DEGs in our PRE-treatment samples.

### Comparative Analysis Across Versions
Our study also aims to examine DEGs for clinical and count data across different versions of the dataset:
- **Orcestra Version**: `clin_orc` and `count_orcestra`.
- **New Version**: `clin_subset` and `count`.

The goal was to ensure the identified DEGs were consistent across both dataset versions. Remarkably, both analyses identified an identical number of significant DEGs, totaling 139 in each, underscoring the robustness and reproducibility of our gene signatures across diverse data structures and analytical approaches.

### Gene Highlights
Notable genes including CFTR, USH2A, HOXA9, LAMB4, MYH7, and CD274 were identified as DEGs. Specifically:
- **LAMB4**: Upregulated in non-responders, highlighting its role in immunosuppressive pathways.
- **CD274 (PD-L1)**: Known for its pivotal role in immune checkpoint pathways, associated with modulation of T cell activity.

This detailed comparison and consistent findings across dataset versions reinforce the reliability of our analytical methods and the significance of the identified DEGs in clinical contexts. 



```{r Fig1A ,  fig.width= 20 , fig.height= 50}

# Define responder and non-responder groups based on the criteria
assign_response_paper <- function(clin_data) {
  clin_data$response_paper <- ifelse(
    clin_data$recist %in% c("CR", "PR") | (clin_data$recist == "SD" & clin_data$survival_time_pfs > 6), 
    "Responder", 
    ifelse(clin_data$recist == "PD" | (clin_data$recist == "SD" & clin_data$survival_time_pfs <= 6), 
           "Non-responder", 
           NA)
  )
  return(clin_data)
}

# Apply the function to both clin_subset and clin_orc
clin_subset <- assign_response_paper(clin_subset)
clin_orc <- assign_response_paper(clin_orc)


# 1. Orcestra count and annotation
expr_gene_counts_orc <- assays(mae_orcestra)[["expr_gene_counts"]] # 61544    41
annot_orc <- data.frame(rowData(mae_orcestra@ExperimentList$expr_gene_counts))

# 2. Newly curated count and annotation
expr_gene_counts <- assays(mae)[["expr_gene_counts"]]
expr_gene_counts <- expr_gene_counts[, clin_orc$patientid] # 61544 X 41 dim
annot <- data.frame(rowData(mae@ExperimentList$expr_gene_counts))

# Remove duplicate genes and set as rownames
annot <- annot[!duplicated(annot$gene_name), ]
annot <- annot[, c("gene_id", "gene_name")]

analyze_gene_expression <- function(expr_gene_counts, annot, clin_subset, treatment_col = "RNA.Sequencing", treatment_pre = "PRE", response_col = "response_paper") {

  # Remove duplicate genes and set as rownames
  annot <- annot[!duplicated(annot$gene_name), ]
  annot <- annot[, c("gene_id", "gene_name")]
  
  # Match gene IDs and gene names, and remove rows without a gene name
  expr_gene_counts$gene_id <- rownames(expr_gene_counts)
  expr_gene_counts <- merge(expr_gene_counts, annot, by = "gene_id")
  expr_gene_counts <- expr_gene_counts[!is.na(expr_gene_counts$gene_name), ]
  rownames(expr_gene_counts) <- expr_gene_counts$gene_name
  expr_gene_counts$gene_id <- NULL
  expr_gene_counts$gene_name <- NULL
  
  # Revert log-transformed data (if necessary)
  expr_gene_counts <- 2^expr_gene_counts - 1
  
  # Define sample subsets for PRE treatments based on treatment_col
  pre_samples <- intersect(clin_subset$patientid[clin_subset[[treatment_col]] == treatment_pre], colnames(expr_gene_counts))
  
  # Subset expression data for PRE samples
  expr_pre <- expr_gene_counts[, pre_samples]
  
  # Subset clin_subset to matching samples for PRE
  clin_pre <- clin_subset[clin_subset$patientid %in% pre_samples, , drop = FALSE]
  
  # Create DESeq2 dataset objects and perform normalization and differential expression analysis
  dds_pre <- DESeqDataSetFromMatrix(countData = round(expr_pre), colData = clin_pre, design = as.formula(paste("~", response_col)))
  
  dds_pre <- DESeq(dds_pre)
  
  res_pre <- results(dds_pre, contrast = c(response_col, "Responder", "Non-responder"))
  
  # Filter significant results
  sig_res_pre <- res_pre[!is.na(res_pre$padj) & res_pre$padj < 0.05, ]
  
  # Compute CPM and log-transform for visualization
  cpm_pre <- cpm(DGEList(counts = expr_pre), log = TRUE, prior.count = 1)
  
  # Subset DEGs
  cpm_pre_degs <- cpm_pre[rownames(sig_res_pre), ]
  
  # Generate heatmap
  pheatmap_pre <- pheatmap(cpm_pre_degs, cluster_rows = TRUE, cluster_cols = TRUE, show_rownames = TRUE, show_colnames = TRUE, color = colorRampPalette(c("blue", "white", "red"))(50), silent = TRUE, main = "PRE Treatment Heatmap (Monotherapy)")
  
  # Return results and heatmaps
  list(
    sig_res_pre = sig_res_pre,
    pheatmap_pre = pheatmap_pre
  )
}

#1. Analyze expr_gene_counts
results <- analyze_gene_expression(expr_gene_counts, annot, clin_subset)
sig_res_pre <- results$sig_res_pre
pheatmap_pre <- results$pheatmap_pre
deg_count <- length(rownames(sig_res_pre))

# 2.Analyze expr_gene_counts_orc
results_orc <- analyze_gene_expression(expr_gene_counts_orc, annot_orc, clin_orc)
sig_res_pre_orc <- results_orc$sig_res_pre
pheatmap_pre_orc <- results_orc$pheatmap_pre
deg_count_orc <- length(rownames(sig_res_pre_orc))

deg_table <- data.frame(
  Dataset = c("expr_gene_counts", "expr_gene_counts_orc"),
  Number_of_DEGs = c(deg_count, deg_count_orc)
)

kable(deg_table, caption = "Number of DEGs in Each Dataset")

grob1 <- pheatmap_pre$gtable
grob2 <- pheatmap_pre_orc$gtable

# Use grid.arrange to plot them side by side
grid.arrange(grob1, grob2, ncol = 2)

# Compare DEGs with a provided paper
DEGS_result_paper <- read_excel("~/BHK lab/ICB/ICB_Gide/files/1-s2.0-S1535610819300376-mmc4.xlsx")
colnames(DEGS_result_paper ) <- DEGS_result_paper [2, ] 
DEGS_result_paper  <- DEGS_result_paper [-c(1:2), ] 
colnames(DEGS_result_paper ) <- str_replace_all(colnames(DEGS_result_paper ), '\\W', '.')

DEGS_paper <- DEGS_result_paper$Gene

if (all(rownames(sig_res_pre_orc) == rownames(sig_res_pre))) { 
  print("All row names match")
} else { 
  print("Row names do not match")
}

# Find the intersection of DEGs from the paper and your results
intersect_genes <- intersect(DEGS_paper, rownames(sig_res_pre))
print(paste("Common DEGs:", paste(intersect_genes, collapse = ", ")))


```


### DEG Analysis Reassessment

Despite both curated DEG sets being identical, demonstrating consistency with the patient data, only 139 DEGs were initially identified, whereas the paper mentions over 300. We employed two approaches for further analysis:

#### Version 1: **Reanalysis with the Complete Clinical Dataset**
In this approach, we reanalyzed the data using the full clinical dataset to determine if including all available patient data influences DEG identification.

#### Version 2: **Reanalysis with the Complete Clinical Dataset Using "Treatment Timepoint"**
In this approach, we used the new "treatment_timepoint" column (extracted from the file `1-s2.0-S1535610819300376-mmc4.xlsx` shared by the author) instead of the "RNA.Sequencing" column. This allowed us to distinguish pre- and post-treatment conditions more accurately.

#### Results
- **Version 1**: We identified 375 DEGs, closely matching the paper’s results.
- **Version 2**: We found 78 DEGs that intersected with the DEGs reported for pre-treatment monotherapy patients. This version almost exactly matches the 328 DEGs mentioned in the paper.

As a result, the newer MAE with the "treatment_timepoint" column provides more accurate results by clearly distinguishing pre- and post-treatment conditions, leading to better alignment with the paper’s findings.


```{r Fig1A complete clinical data(new), fig.width= 9 , fig.height= 20}

# Newly curated count and annotation
expr_gene_counts <- assays(mae)[["expr_gene_counts"]]  # dim 61544 x 91
annot <- data.frame(rowData(mae@ExperimentList$expr_gene_counts))
clin <- data.frame(colData(mae))
clin <- assign_response_paper(clin) 

# 1. Analyze expr_gene_counts with complete clinical data for 91 patients and retain RNA.Sequencing
results_complete <- analyze_gene_expression(expr_gene_counts, annot, clin)
sig_res_pre1 <- results_complete$sig_res_pre
pheatmap_pre1 <- results_complete$pheatmap_pre
deg_count1 <- length(rownames(sig_res_pre1))  # This is 375 DEGs

# Find intersecting DEGs with DEGS_paper
intersect_genes1 <- intersect(DEGS_paper, rownames(sig_res_pre1))  # 78 intersecting genes
print(paste0("Total DEGs: ", deg_count1, 
             "; Common DEGs: ", length(intersect_genes1), 
             "; Genes: ", paste(intersect_genes1, collapse = ", ")))


# Filter patients that are in both clinical data and expression data
patients <- intersect(clin$patientid, colnames(expr_gene_counts))
clin <- clin[clin$patientid %in% patients, ]  # Filter clinical data to matching patients
expr_gene_counts <- expr_gene_counts[, patients]  # Subset expression data to matching patients

# 2. Run analysis for the subset of patients
results_complete2 <- analyze_gene_expression(expr_gene_counts, annot, clin, treatment_col = "treatment_timepoint", treatment_pre = "PRE")
sig_res_pre2 <- results_complete2$sig_res_pre
pheatmap_pre2 <- results_complete2$pheatmap_pre
deg_count2 <- length(rownames(sig_res_pre2))  # DEG 326

# Find intersecting DEGs with DEGS_paper for second run
intersect_genes2 <- intersect(DEGS_paper, rownames(sig_res_pre2)) #46 same genes

# Print DEG counts and intersections
print(paste0("Total DEGs: ", deg_count2, 
             "; Common DEGs: ", length(intersect_genes2), 
             "; Genes: ", paste(intersect_genes2, collapse = ", ")))

# Extract grobs from pheatmap objects
grob1 <- pheatmap_pre1$gtable
grob2 <- pheatmap_pre2$gtable

# Display the first heatmap with a caption
grid.arrange(grob1, ncol = 1, top = textGrob("Heatmap 1: Monotherapy", gp = gpar(fontsize = 14, fontface = "bold")))
```


```{r pheatmap2 , fig.width= 13 , fig.height= 70}
# Display the second heatmap with a caption
grid.arrange(grob2, ncol = 1, top = textGrob("Heatmap 2: Combination Therapy", gp = gpar(fontsize = 14, fontface = "bold")))


```

### Associated enriched KEGG signaling pathways (nominal p < 0.05) for anti-PD-1 monotherapy(PRE samples)


This analysis aims to identify and compare enriched KEGG signaling pathways in pre-treatment and early during treatment (EDT) samples from anti-PD-1 monotherapy. The focus is on statistically significant pathways (nominal p < 0.05) and comparing them with known immune-related pathways from the literature.

#### Pathway Data
KEGG pathways were sourced from the file `c2.cp.kegg.v7.4.symbols.gmt`.

#### Analysis Steps
1. **Gene Ranking**: Genes were ranked by the negative log10 of their p-values, derived from differential expression analysis.
2. **Gene Set Enrichment Analysis (GSEA)**: Conducted using the `fgsea` package to determine pathway enrichment.
3. **Results Filtering**: Emphasis was on pathways with adjusted p-values less than 0.05.
4. **Literature Comparison**: Enriched pathways were evaluated against a predefined list of immune response pathways to identify overlaps.

**Common Pathways**: KEGG_CHEMOKINE_SIGNALING_PATHWAY, KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY were identified in our DEG analysis using the complete clinical data, with the new `treatment_timepoint` column.

```{r Fig1B, fig.width= 9}

# Load KEGG pathways for MEDICUS
pathwaysKEG <- gmtPathways("~/BHK lab/ICB/ICB_Gide/files/c2.cp.kegg.v7.4.symbols.gmt")

# 1. Perform GSEA for sig_res_pre2 (Monotherapy - Pre-treatment and EDT)
# Rank genes by -log10 of p-value
ranked_genes1 <- -log10(sig_res_pre2$pvalue)
names(ranked_genes1) <- rownames(sig_res_pre2)

# Perform fgsea for sig_res_pre2 (Monotherapy)
fgsea_results1 <- fgsea(pathways = pathwaysKEG, stats = ranked_genes1)

# Tidy and filter results for fgsea (Significance at nominal p < 0.05)
fgsea_tidy1 <- fgsea_results1 %>%
  as_tibble() %>%
  arrange(desc(NES)) %>%
  mutate(Significance = ifelse(padj <= 0.05, "Significant", "Not Significant"))

fgsea_tidy1_top <- head(fgsea_tidy1, 10)  
kable(fgsea_tidy1_top, caption = "Top 10 KEGG Pathway Enrichment Results for Monotherapy (Pre-treatment & EDT)")

# Generate a plot for KEGG pathway enrichment in Monotherapy (Figure 1B)
ggplot(fgsea_tidy1[fgsea_tidy1$pval < 0.05, ], aes(reorder(pathway, NES), NES, fill = Significance)) +
  geom_col() +
  scale_fill_manual(values = c("Significant" = "red", "Not Significant" = "blue")) +
  coord_flip() +
  theme_minimal() +
  labs(x = "Pathway", y = "Normalized Enrichment Score (NES)", 
       title = "KEGG Pathway Enrichment - Monotherapy (Pre-treatment & EDT)") +
  theme(axis.text.y = element_text(size = 10), axis.title.x = element_text(size = 12))

# Pathways mentioned in the paper
paper_pathways <- c(
  "KEGG_STARCH_AND_SUCROSE_METABOLISM",
  "KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS",
  "KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450",
  "KEGG_RETINOL_METABOLISM",
  "KEGG_LINOLEIC_ACID_METABOLISM",
  "KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY",
  "KEGG_CHEMOKINE_SIGNALING_PATHWAY",
  "KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",
  "KEGG_NEUROTROPHIN_SIGNALING_PATHWAY",
  "KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION",
  "KEGG_JAK_STAT_SIGNALING_PATHWAY"
)

# Pathways from fgsea_tidy1_top
fgsea_pathways <- fgsea_tidy1_top$pathway

# Find the intersection between the two
common_pathways <- intersect(paper_pathways, fgsea_pathways)

# Print the common pathways
print(paste("Common Pathways:", paste(common_pathways, collapse = ", ")))


```
